Chronic Leg Ulcer
8
2
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
1 terminated out of 8 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers
A PMCF Investigation on Chronic LU and DFU in Need of Debridement With ChloraSolv®
Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western Kenya
Oxygen Wound Therapy Feasibility Study
Safety and Tolerability of Single and Multiple Doses of SoftOx Biofilm Eradicator (SBE) in Chronic Leg Wounds
Positive Predictive Value (PPV) of Pseudomonas Aeruginosa
Efficacy of 50% Nitrous Oxide/50% Oxygen Gas Premix in Chronic Leg Ulcer Debridement
Autologous Bone Marrow Stem Cells for Chronic Leg Ulcer Treatment in Sickle Cell Disease